FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:300-302 July 21, 2005 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Service, G. J. PubMed Citation

As the obesity pandemic continues to worsen and medical interventions remain only moderately effective, bariatric surgery is at present the only method that reliably results in major, long-term weight loss.^1,2 The most successful procedures durably reduce body weight by about one third and ameliorate nearly all obesity-related complications, most notably — almost miraculously — type 2 diabetes mellitus.² Not surprisingly, bariatrics is the fastest-growing surgical subspecialty. The number of bariatric surgeons registered with the American Society for Bariatric Surgery increased by almost 50 percent per year during the past several years, and the number of bariatric operations nearly doubles annually.³ . . . [Full Text of this Article]

Source Information

From the Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, and Veterans Affairs Puget Sound Health Care System, Seattle.

Related Letters:

Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery
Carpenter T., Trautmann M. E., Baron A. D., Kaiser A. M., Service F. J., Thompson G. B., Lloyd R. V., Cummings D. E., Shannon M. H., Carlson M. J.
Extract | Full Text | PDF  
N Engl J Med 2005; 353:2192-2194, Nov 17, 2005. Correspondence

This article has been cited by other articles:

• Thaler, J. P., Cummings, D. E. (2009). Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery. Endocrinology 150: 2518-2525 [Abstract] [Full Text]  
• Vidal, J., Nicolau, J., Romero, F., Casamitjana, R., Momblan, D., Conget, I., Morinigo, R., Lacy, A. M. (2009). Long-Term Effects of Roux-en-Y Gastric Bypass Surgery on Plasma Glucagon-Like Peptide-1 and Islet Function in Morbidly Obese Subjects. J. Clin. Endocrinol. Metab. 94: 884-891 [Abstract] [Full Text]  
• Bult, M. J F, van Dalen, T., Muller, A. F (2008). Surgical treatment of obesity. Eur J Endocrinol 158: 135-145 [Abstract] [Full Text]  
• Cummings, D. E., Flum, D. R. (2008). Gastrointestinal Surgery as a Treatment for Diabetes. JAMA 299: 341-343 [Full Text]  
• Vella, A., Service, F. J. (2007). Incretin Hypersecretion in Post-Gastric Bypass Hypoglycemia Primary Problem or Red Herring?. J. Clin. Endocrinol. Metab. 92: 4563-4565 [Full Text]  
• Khoo, T.-K., Service, F. J. (2006). 47-Year-Old Woman With Spells of Slurred Speech, Blurred Vision, and Loss of Consciousness. Mayo Clin Proc. 81: 1495-1498 [Full Text]  
• Meier, J. J., Butler, A. E., Galasso, R., Butler, P. C. (2006). Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased {beta}-Cell Turnover. Diabetes Care 29: 1554-1559 [Abstract] [Full Text]  
• Carpenter, T., Trautmann, M. E., Baron, A. D., Kaiser, A. M., Service, F. J., Thompson, G. B., Lloyd, R. V., Cummings, D. E., Shannon, M. H., Carlson, M. J. (2005). Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery. NEJM 353: 2192-2194 [Full Text]